UCB - Market Capitalization

Stock Price
268.20
Daily Change
-2.00 -0.74%
Monthly
3.55%
Yearly
44.89%
Q1 Forecast
269.39

UCB reported EUR51.5B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 29.11B 5.61B Sep/2025
Almirall EUR 2.73B 442.82M Feb/2026
Amarin USD 341M 4M Sep/2025
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Orion EUR 7.27B 1.67B Feb/2026
Recordati EUR 9.81B 343.76M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Unibail Rodamco EUR 11.62B 1.25B Jun/2025